A Phase 1 study of ADI-PEG20 (pegargiminase) combined with cisplatin and pemetrexed in ASS1-negative metastatic uveal melanoma.
Pigment Cell Melanoma Res
; 35(4): 461-470, 2022 07.
Article
in En
| MEDLINE
| ID: mdl-35466524
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Neoplasms, Second Primary
/
Melanoma
Limits:
Humans
Language:
En
Journal:
Pigment Cell Melanoma Res
Year:
2022
Document type:
Article